ABT vs GHM · P/E 25, rev $44.33B vs P/E 79, rev $245.3M
Abbott Laboratories (ABT) versus Graham Corporation (GHM) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Graham Corporation (GHM) is a specialty industrial machinery company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported GHM revenue for 2026-03-31 was $245.3M. Net income was $12.5M. Revenue was up 16.9% from 2025-03-31 to 2026-03-31. GHM currently screens at market cap $1.19B and trailing P/E 79.3.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. GHM currently screens at market cap $1.19B and trailing P/E 79.3.
Not investment advice. Open the ABT and GHM stock pages for the full models.
Not investment advice.